PREMIER INC. and 11 Leading Health Systems Invest in EXELA Pharma Sciences to Secure and Support U.S. – Based Drug Supply and Manufacturing Drug shortages have long plagued U.S. healthcare providers; COVID-19 has compounded sourcing challenges New initiative will manufacture pharmaceutical products in North Carolina, primarily using APIs from the U.S. and Europe Media Contact:Premier – Noah Zachary212.901.1251Public_Relations@premierinc.com CHARLOTTE, N.C., September 8, 2021 ─ Premier Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, and 11 leading health systems acquired a minority stake in Exela Holdings, Inc., the holding company of Exela® Pharma Sciences, LLC, to secure vital supply of
Read More